U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Search AHRQ

For an exact phrase match, enclose search terms in double quotes.

Go to Advanced Search
Go to Basic Search

Results

Total Results: 7,637 records

Showing results for "therapy".

  1. Recommendation: Syphilis Infection During Pregnancy: Screening | United States Preventive Services Taskforce

    www.uspreventiveservicestaskforce.org/uspstf/recommendation/syphilis-infection-in-pregnancy-screening
    May 13, 2025 - longer duration of treatment. … Harms of Screening and Treatment Potential harms of screening for and treatment of syphilis infection … harms, 1 small study (n = 39) reported that 5.1% of patients receiving penicillin therapy experienced … However, benefits were still seen when screening and treatment occurred later in pregnancy. … reaction from treatment with antibiotic medications.

  2. Archived: Iron Deficiency Anemia in Pregnant Women: Screening and Supplementation | United States Preventive Services Taskforce

    www.uspreventiveservicestaskforce.org/uspstf/recommendation/iron-deficiency-anemia-in-pregnant-women-screening-and-supplementation-september-2015
    September 07, 2015 - Treatment Treatment of iron deficiency anemia in pregnant women is similar to that in nonpregnant women … Potential Harms of Screening and Treatment Screening and Treatment No good- or fair-quality studies … reported on the harms of screening or early treatment. 2 Potential harms of iron treatment include … The USPSTF also clarified that intravenous iron treatment is a potential therapy that is offered in current … Treatments for iron-deficiency anaemia in pregnancy.

  3. Case Example #1: Stanford Coordinated Care | Agency for Healthcare Research and Quality

    www.ahrq.gov/ncepcr/tools/workforce-financing/case-example-1.html
    July 01, 2019 - its patient portal so patients have access to the team and to information about their conditions and treatments … LCSW Behavioral health counseling   .6 PT Specialized in use of integrative physical therapy … reviews patient problems while a computer screen is visible to the patient so if the patient asks about a treatment

  4. S38 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/s38.pdf
    October 01, 2007 - If education or evidence leads providers to conclude that 1 therapeutic approach is preferred over others … Thus, measures of agreement in treatments received by patients of different providers within a practice … Improving drug-therapy decisions through educa- tional outreach: a randomized controlled trial of academically … Explained variation in a model of therapeutic decision making is partitioned across patient, physician … A review of use of health care utilization databases for epidemiologic research on therapeutics.

  5. Cancer Older Adults (pdf file)

    www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/cancer_older_adults.pdf
    September 28, 2012 - B tolerate lumpectomy and hormone therapy in light her of CHF and Parkinson disease? … Harms of Disease Treatment. … whether their illnesses and treatments interacted with each other. … Treatments for Localized Prostate Cancer: Systematic Review to Update the 2002 U.S. … The study to understand prognosis and preferences for outcomes and risks of treatments.

  6. Nonsteroidal Anti-inflammatory Drugs and Cyclooxygenase-2 Inhibitors for Primary Prevention of Colorectal Cancer: A Systematic Review (pdf file)

    www.uspreventiveservicestaskforce.org/home/getfilebytoken/EppFbhnDEX5UtYWrTkLEhT
    March 01, 2007 - The Celecoxib Long-Term Arthritis Safety Study (CLASS) (74), Therapeutic Arthritis Research and Gastro … Efficacy and safety of valdecoxib for treatment of osteoarthritis and rheumatoid arthritis: systematic … Efficacy, tolerability, and upper gastroin- testinal safety of celecoxib for treatment of osteoarthritis … Effects of long-term sulindac therapy on colonic polyposis. Ann Intern Med. 1991;115: 952-4. … Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal

  7. Maskedstats Nis 2021 Core (pdf file)

    hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2021_Core.PDF
    January 01, 2021 - uniform) 6,655,903 1 6 2.1 2 14,148,700 PCLASS_ORPROC : Indicates operating room (major diagnostic or therapeutic … ABUSE OR DEPENDENCE, LEFT AMA 11,051 0.17% 895: ALCOHOL, DRUG ABUSE OR DEPENDENCE WITH REHABILITATION THERAPY … 5,955 0.09% 896: ALCOHOL, DRUG ABUSE OR DEPENDENCE WITHOUT REHABILITATION THERAPY WITH MCC 15,525 … 0.23% 897: ALCOHOL, DRUG ABUSE OR DEPENDENCE WITHOUT REHABILITATION THERAPY WITHOUT MCC 59,351 0.89% … WITH MCC 7,946 0.12% 920: COMPLICATIONS OF TREATMENT WITH CC 7,078 0.11% 921: COMPLICATIONS OF TREATMENT

  8. Maskedstats Nis 2020 Core V2 (pdf file)

    hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2020_Core_V2.PDF
    January 01, 2020 - uniform) 6,462,264 1 6 2.1 2 13,683,349 PCLASS_ORPROC : Indicates operating room (major diagnostic or therapeutic … ABUSE OR DEPENDENCE, LEFT AMA 10,209 0.16% 895: ALCOHOL, DRUG ABUSE OR DEPENDENCE WITH REHABILITATION THERAPY … 5,907 0.09% 896: ALCOHOL, DRUG ABUSE OR DEPENDENCE WITHOUT REHABILITATION THERAPY WITH MCC 13,512 … 0.21% 897: ALCOHOL, DRUG ABUSE OR DEPENDENCE WITHOUT REHABILITATION THERAPY WITHOUT MCC 59,233 0.92% … WITH MCC 7,093 0.11% 920: COMPLICATIONS OF TREATMENT WITH CC 6,534 0.10% 921: COMPLICATIONS OF TREATMENT

  9. Maskedstats Nis 2022 Core (pdf file)

    hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2022_Core.PDF
    January 01, 2022 - uniform) 6,568,727 1 6 2.1 2 13,785,029 PCLASS_ORPROC : Indicates operating room (major diagnostic or therapeutic … ABUSE OR DEPENDENCE, LEFT AMA 10,170 0.15% 895: ALCOHOL, DRUG ABUSE OR DEPENDENCE WITH REHABILITATION THERAPY … 6,159 0.09% 896: ALCOHOL, DRUG ABUSE OR DEPENDENCE WITHOUT REHABILITATION THERAPY WITH MCC 15,980 … 0.24% 897: ALCOHOL, DRUG ABUSE OR DEPENDENCE WITHOUT REHABILITATION THERAPY WITHOUT MCC 54,553 0.83% … WITH MCC 8,364 0.13% 920: COMPLICATIONS OF TREATMENT WITH CC 7,139 0.11% 921: COMPLICATIONS OF TREATMENT

  10. Maskedstats Nis 2017 Core Weighted (pdf file)

    hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2017_Core_Weighted.PDF
    January 01, 2017 - ABUSE OR DEPENDENCE, LEFT AMA 48,105 0.13% 895: ALCOHOL/DRUG ABUSE OR DEPENDENCE W REHABILITATION THERAPY … 31,180 0.09% 896: ALCOHOL/DRUG ABUSE OR DEPENDENCE W/O REHABILITATION THERAPY W MCC 53,200 0.15% 897 … : ALCOHOL/DRUG ABUSE OR DEPENDENCE W/O REHABILITATION THERAPY W/O MCC 329,050 0.92% 901: WOUND DEBRIDEMENTS … 142,555 0.40% 918: POISONING & TOXIC EFFECTS OF DRUGS W/O MCC 144,170 0.40% 919: COMPLICATIONS OF TREATMENT … W MCC 31,290 0.09% 920: COMPLICATIONS OF TREATMENT W CC 37,885 0.11% 921: COMPLICATIONS OF TREATMENT

  11. Maskedstats Nis 2019 Core V2 (pdf file)

    hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2019_Core_V2.PDF
    January 01, 2019 - uniform) 7,074,980 1 6 2.1 2 14,796,847 PCLASS_ORPROC : Indicates operating room (major diagnostic or therapeutic … ABUSE OR DEPENDENCE, LEFT AMA 10,232 0.14% 895: ALCOHOL/DRUG ABUSE OR DEPENDENCE W REHABILITATION THERAPY … 6,110 0.09% 896: ALCOHOL/DRUG ABUSE OR DEPENDENCE W/O REHABILITATION THERAPY W MCC 11,770 0.17% 897 … : ALCOHOL/DRUG ABUSE OR DEPENDENCE W/O REHABILITATION THERAPY W/O MCC 65,288 0.92% 901: WOUND DEBRIDEMENTS … W MCC 7,676 0.11% 920: COMPLICATIONS OF TREATMENT W CC 8,163 0.12% please refer to the section on

  12. Maskedstats Nis 2016 Core Weighted (pdf file)

    hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2016_Core_Weighted.PDF
    January 01, 2016 - ABUSE OR DEPENDENCE, LEFT AMA 47,625 0.13% 895: ALCOHOL/DRUG ABUSE OR DEPENDENCE W REHABILITATION THERAPY … 27,660 0.08% 896: ALCOHOL/DRUG ABUSE OR DEPENDENCE W/O REHABILITATION THERAPY W MCC 47,325 0.13% 897 … : ALCOHOL/DRUG ABUSE OR DEPENDENCE W/O REHABILITATION THERAPY W/O MCC 333,580 0.94% 901: WOUND DEBRIDEMENTS … 136,190 0.38% 918: POISONING & TOXIC EFFECTS OF DRUGS W/O MCC 155,215 0.44% 919: COMPLICATIONS OF TREATMENT … W MCC 28,565 0.08% 920: COMPLICATIONS OF TREATMENT W CC 36,305 0.10% 921: COMPLICATIONS OF TREATMENT

  13. Maskedstats Nrd 2019 Core Weighted V2 (pdf file)

    hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2019_Core_Weighted_V2.PDF
    January 01, 2019 - 18,109,651 23,205 1.00 6.00 2.07 0.01 PCLASS_ORPROC Indicates operating room (major diagnostic or therapeutic … ABUSE OR DEPENDENCE, LEFT AMA 54,297 0.15% 895: ALCOHOL/DRUG ABUSE OR DEPENDENCE W REHABILITATION THERAPY … 37,417 0.11% 896: ALCOHOL/DRUG ABUSE OR DEPENDENCE W/O REHABILITATION THERAPY W MCC 56,501 0.16% … 897: ALCOHOL/DRUG ABUSE OR DEPENDENCE W/O REHABILITATION THERAPY W/O MCC 339,351 0.96% 901: WOUND … W MCC 37,836 0.11% 920: COMPLICATIONS OF TREATMENT W CC 40,956 0.12% 921: COMPLICATIONS OF TREATMENT

  14. Maskedstats Nrd 2016 Core (pdf file)

    hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2016_Core.PDF
    January 01, 2016 - ABUSE OR DEPENDENCE, LEFT AMA 28,857 0.17% 895: ALCOHOL/DRUG ABUSE OR DEPENDENCE W REHABILITATION THERAPY … 20,951 0.12% 896: ALCOHOL/DRUG ABUSE OR DEPENDENCE W/O REHABILITATION THERAPY W MCC 23,051 0.13% … 897: ALCOHOL/DRUG ABUSE OR DEPENDENCE W/O REHABILITATION THERAPY W/O MCC 171,683 1.00% 901: WOUND … MCC 60,848 0.35% 918: POISONING & TOXIC EFFECTS OF DRUGS W/O MCC 65,296 0.38% 919: COMPLICATIONS OF TREATMENT … W MCC 14,723 0.09% 920: COMPLICATIONS OF TREATMENT W CC 19,579 0.11% 921: COMPLICATIONS OF TREATMENT

  15. Maskedstats Nrd 2021 Core (pdf file)

    hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2021_CORE.PDF
    January 01, 2021 - 16,776,320 29,188 1.00 6.00 2.03 2 34,079,234 PCLASS_ORPROC : Indicates operating room (major diagnostic or therapeutic … ABUSE OR DEPENDENCE, LEFT AMA 32,646 0.19% 895: ALCOHOL, DRUG ABUSE OR DEPENDENCE WITH REHABILITATION THERAPY … 19,624 0.12% 896: ALCOHOL, DRUG ABUSE OR DEPENDENCE WITHOUT REHABILITATION THERAPY WITH MCC 41,892 … DRG_NoPOA Frequency Percent of Total 897: ALCOHOL, DRUG ABUSE OR DEPENDENCE WITHOUT REHABILITATION THERAPY … WITH MCC 21,194 0.13% 920: COMPLICATIONS OF TREATMENT WITH CC 19,763 0.12% 921: COMPLICATIONS OF TREATMENT

  16. Maskedstats Nrd 2019 Core V2 (pdf file)

    hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2019_CORE_V2.PDF
    January 01, 2019 - 18,109,651 23,205 1.00 6.00 2.01 2 36,320,623 PCLASS_ORPROC : Indicates operating room (major diagnostic or therapeutic … ABUSE OR DEPENDENCE, LEFT AMA 31,545 0.17% 895: ALCOHOL/DRUG ABUSE OR DEPENDENCE W REHABILITATION THERAPY … 22,134 0.12% 896: ALCOHOL/DRUG ABUSE OR DEPENDENCE W/O REHABILITATION THERAPY W MCC 32,004 0.18% … 897: ALCOHOL/DRUG ABUSE OR DEPENDENCE W/O REHABILITATION THERAPY W/O MCC 182,163 1.00% 901: WOUND … W MCC 21,099 0.12% 920: COMPLICATIONS OF TREATMENT W CC 22,875 0.13% 921: COMPLICATIONS OF TREATMENT

  17. Maskedstats Nrd 2018 Core (pdf file)

    hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2018_Core.PDF
    January 01, 2018 - ABUSE OR DEPENDENCE, LEFT AMA 29,979 0.17% 895: ALCOHOL/DRUG ABUSE OR DEPENDENCE W REHABILITATION THERAPY … 22,420 0.13% 896: ALCOHOL/DRUG ABUSE OR DEPENDENCE W/O REHABILITATION THERAPY W MCC 29,071 0.16% … 897: ALCOHOL/DRUG ABUSE OR DEPENDENCE W/O REHABILITATION THERAPY W/O MCC 173,088 0.98% 901: WOUND … MCC 67,062 0.38% 918: POISONING & TOXIC EFFECTS OF DRUGS W/O MCC 58,270 0.33% 919: COMPLICATIONS OF TREATMENT … W MCC 18,937 0.11% 920: COMPLICATIONS OF TREATMENT W CC 21,943 0.12% 921: COMPLICATIONS OF TREATMENT

  18. Kid 2019 Maskedstats Core V2 (pdf file)

    hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2019_MaskedStats_Core_V2.PDF
    January 01, 2019 - uniform) 3,084,974 1 6 2.6 2 8,107,946 PCLASS_ORPROC : Indicates operating room (major diagnostic or therapeutic … DRUG ABUSE OR DEPENDENCE, LEFT AMA 378 0.01% 895: ALCOHOL/DRUG ABUSE OR DEPENDENCE W REHABILITATION THERAPY … 395 0.01% 896: ALCOHOL/DRUG ABUSE OR DEPENDENCE W/O REHABILITATION THERAPY W MCC 684 0.02% 897: ALCOHOL … /DRUG ABUSE OR DEPENDENCE W/O REHABILITATION THERAPY W/O MCC 5,067 0.16% 901: WOUND DEBRIDEMENTS FOR … W MCC 1,386 0.04% 920: COMPLICATIONS OF TREATMENT W CC 1,026 0.03% 921: COMPLICATIONS OF TREATMENT

  19. Kid 2016 Maskedstats Core (pdf file)

    hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2016_MaskedStats_Core.PDF
    January 01, 2016 - DRUG ABUSE OR DEPENDENCE, LEFT AMA 569 0.02% 895: ALCOHOL/DRUG ABUSE OR DEPENDENCE W REHABILITATION THERAPY … 579 0.02% 896: ALCOHOL/DRUG ABUSE OR DEPENDENCE W/O REHABILITATION THERAPY W MCC 597 0.02% 897: ALCOHOL … /DRUG ABUSE OR DEPENDENCE W/O REHABILITATION THERAPY W/O MCC 5,967 0.19% 901: WOUND DEBRIDEMENTS FOR … MCC 5,630 0.18% 918: POISONING & TOXIC EFFECTS OF DRUGS W/O MCC 24,835 0.80% 919: COMPLICATIONS OF TREATMENT … W MCC 1,131 0.04% 920: COMPLICATIONS OF TREATMENT W CC 961 0.03% 921: COMPLICATIONS OF TREATMENT W

  20. Cancer-Pancreas Research-Protocol (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-pancreas_research-protocol.pdf
    August 09, 2013 - unresectable cases, however, a biopsy is taken and a formal stage is determined to guide the planning of treatments … that some Stage III cases are borderline resectable and may be appropriate targets for neoadjuvant therapy … adenocarcinoma is fatal if untreated, so it is critical to choose the right imaging test and initiate therapy … Were the study results unaffected by intervening treatments or disease progression/regression? … of patients receiving each specific ancillary treatment?
SHARE:
Facebook Twitter Print Facebook Share

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

Click to show only results for the selected site.

psnet.ahrq.gov (2370)

effectivehealthcare.ahrq.gov (1640)

www.ahrq.gov (1577)

www.uspreventiveservicestaskforce.org (783)

digital.ahrq.gov (588)

hcup-us.ahrq.gov (448)

cds.ahrq.gov (85)

integrationacademy.ahrq.gov (77)

meps.ahrq.gov (45)

cdsic.ahrq.gov (17)

pso.ahrq.gov (3)

qualityindicators.ahrq.gov (3)

datatools.ahrq.gov (1)